Dexcom (DXCM) Notes Payables (2022 - 2025)
Dexcom's (DXCM) quarterly Notes Payables came in at $1.2 billion in Q3 2025, little changed on a QoQ basis from $1.2 billion in Q2 2025.
Dexcom (DXCM) Notes Payables (2022 - 2025) Analysis & Trends
Dexcom (DXCM) has 4 years of Notes Payables data on file, last reported at $1.2 billion in Q3 2025.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $1.2 billion in Q3 2025; TTM through Sep 2025 was $1.2 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $1.2 billion, changed N/A from the prior year.
- Notes Payables for Q3 2025 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
- Over the last five years, Notes Payables for DXCM reached as high as $1.2 billion in Q3 2025 and fell as low as $124.2 million in Q3 2023.
- Historically, Notes Payables has averaged $908.3 million across 4 years, with a median of $989.1 million in 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.21 Bn |
| Mar 31, 2025 | 1.21 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2023 | 124.20 Mn |
| Jun 30, 2023 | 773.80 Mn |
| Mar 31, 2023 | 773.20 Mn |
| Dec 31, 2022 | 772.60 Mn |